| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $326,321,486 ) (Continued on the next page) |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | F32AG099362 | A Novel Mechanism of Autophagic Degradation in Cellular Senescence | 001 | 1 | NIH | 4/1/2026 | $1,260 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | F32AG099362 | A Novel Mechanism of Autophagic Degradation in Cellular Senescence | 000 | 1 | NIH | 2/20/2026 | $78,250 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R13EB039477 | Endorsed ISMRM Workshop on MRI of Neuromodulation | 000 | 1 | NIH | 4/3/2026 | $10,000 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R61DA061328 | Reimagining "Plans of Safe Care:" Promoting Recovery, Family Well-being, and Engendering Trust through Family Care Planning | 000 | 1 | NIH | 4/27/2026 | $532,166 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AG094755 | Optimizing High-Resolution MRI for Analyzing Perivascular Space Dynamics and Waste Clearance in Alzheimer's Disease | 001 | 1 | NIH | 5/25/2026 | $0 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AG094755 | Optimizing High-Resolution MRI for Analyzing Perivascular Space Dynamics and Waste Clearance in Alzheimer's Disease | 000 | 1 | NIH | 4/13/2026 | $670,530 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HL180648 | Menopause-related Vasomotor Symptoms and Cardiovascular Health | 001 | 2 | NIH | 5/22/2026 | $739,229 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | F32EY037508 | Multifunctional Imaging of the Optic Nerve Head in Glaucoma | 001 | 1 | NIH | 6/11/2026 | $0 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | F32EY037508 | Multifunctional Imaging of the Optic Nerve Head in Glaucoma | 000 | 1 | NIH | 6/11/2026 | $82,480 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HD121977 | Perinatal human cerebellum development: high-resolution in-vivo and ex-vivo imaging | 000 | 1 | NIH | 6/25/2026 | $681,793 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AG087790 | Clinical Spectrum and Societal Impact of Cognitive Impairment, Alzheimer's and Related Dementias among people with HIV in Uganda | 002 | 1 | NIH | 3/28/2026 | $112,527 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AG087790 | Clinical Spectrum and Societal Impact of Cognitive Impairment, Alzheimer's and Related Dementias among people with HIV in Uganda | 001 | 1 | NIH | 3/27/2026 | $143,326 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AG087790 | Clinical Spectrum and Societal Impact of Cognitive Impairment, Alzheimer's and Related Dementias among people with HIV in Uganda | 000 | 1 | NIH | 2/3/2026 | $738,105 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HD120371 | Metabolic Assessment of Metformin in Pregnancy (MoM-P) | 000 | 1 | NIH | 6/19/2026 | $672,715 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | UG3DA063527 | Advancing an inexpensive, wearable prefrontal cortex fNIRS device and integrated software for assessment of cerebral biomarkers of intoxication in real world settings | 000 | 1 | NIH | 6/19/2026 | $676,305 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K01DK147856 | Precision Metabolic Risk Stratification in Depression via Multi-Omics and EHR | 000 | 1 | NIH | 6/19/2026 | $156,510 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AG098476 | The Coma Family Program (COMA-F): A multi-site clinical trial of a resilience program for caregivers of patients with severe acute brain injury | 001 | 1 | NIH | 2/9/2026 | $0 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AG098476 | The Coma Family Program (COMA-F): A multi-site clinical trial of a resilience program for caregivers of patients with severe acute brain injury | 000 | 1 | NIH | 2/3/2026 | $722,746 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01EY038655 | High-resolution corneal hydration mapping using Brillouin microscopy | 000 | 1 | NIH | 6/16/2026 | $643,357 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | S10OD040131 | VisualSonics Vevo F2 LAZR-X20 Photoacoustic and Ultrasound Imaging System | 000 | 1 | NIH | 5/5/2026 | $1,061,520 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R21AI196804 | Ex-Vivo Machine Perfusion To Promote Tolerance Induction in Deceased Donor Kidney Transplantation | 000 | 1 | NIH | 2/23/2026 | $416,622 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R21AI196488 | The GI tract in Systemic Alloimmunity | 000 | 1 | NIH | 2/6/2026 | $436,454 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AG098906 | PET imaging of alpha-synuclein pathology | 000 | 1 | NIH | 2/4/2026 | $677,276 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R03DK145781 | Audible diabetesRx: An audio-based digital tool to address health literacy barriers to medication adherence in type 2 diabetes | 000 | 1 | NIH | 2/4/2026 | $123,750 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R21AG096539 | ROOTS: Revealing cognitive Outcomes in 'zeroth gen' Older immigranTS | 000 | 1 | NIH | 2/3/2026 | $453,750 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01DA062848 | Genomic Tests for Substance Use Disorders in Clinical Care: Examining Challenges and Opportunities | 000 | 1 | NIH | 2/26/2026 | $769,268 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AI195674 | Decoding the neuroimmune control of cutaneous gamma/delta cell function in allergic immunity | 000 | 1 | NIH | 2/9/2026 | $776,034 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R21HL184268 | Using sleep EEG for tracking longitudinal changes in brain state and waketime cognitive function | 000 | 1 | NIH | 5/1/2026 | $266,541 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R00HL169733 | Whole genome sequence interpretation for lipids to discover new genes and mechanisms for coronary artery disease | 000 | 3 | NIH | 4/2/2026 | $249,000 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AI202406 | Sensory neuron metabolic remodeling establishes neuroimmune memory and amplifies immunity | 000 | 1 | NIH | 7/3/2026 | $785,998 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01MH138281 | Electronic Partner Notification for STIs: A Syndemic Approach to Improve HIV and STI Service Access in MA | 000 | 1 | NIH | 3/19/2026 | $855,983 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K99AR084551 | Non-canonical transcriptional activation of MITF in pigment cells. | 000 | 1 | NIH | 4/8/2026 | $107,784 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K23AG090699 | CONNECT: A Diagnostic Disclosure Communication Intervention in Dementia Care | 000 | 1 | NIH | 7/3/2026 | $197,555 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01DK146964 | GPAT2 REGULATES MINERAL METABOLISM IN KIDNEY DISEASE | 000 | 1 | NIH | 4/8/2026 | $622,959 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R03DA064903 | Uncovering Patterns in the Evolving Drug Supply to Detect Emerging Overdose Trends Using Machine Learning | 001 | 1 | NIH | 4/3/2026 | -$62,000 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R03DA064903 | Uncovering Patterns in the Evolving Drug Supply to Detect Emerging Overdose Trends Using Machine Learning | 000 | 1 | NIH | 3/9/2026 | $330,000 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01AG093843 | Sleep and Circadian Rhythm Biomarkers of Postoperative Neurocognitive Recovery (SLEEP-POD2) | 000 | 1 | NIH | 2/18/2026 | $868,901 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R13DA064375 | Joint Meeting on Youth Prevention, Treatment, and Recovery | 000 | 1 | NIH | 4/17/2026 | $24,980 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R21AG093037 | Deep templates for longitudinal morphometry in Alzheimer's disease | 000 | 1 | NIH | 3/12/2026 | $660,000 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K23DK143316 | Optimizing Glycemic Monitoring and Management in People with Type 2 Diabetes and Chronic Kidney Disease | 000 | 1 | NIH | 3/19/2026 | $197,320 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K01DK146206 | c-Kit receptor signaling in the modulation of collecting duct function | 001 | 1 | NIH | 5/14/2026 | $29,896 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K01DK146206 | c-Kit receptor signaling in the modulation of collecting duct function | 000 | 1 | NIH | 3/19/2026 | $110,865 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | K23AT013273 | Toolkit for Optimal Pain Management in the Emergency Department: A mind-body intervention for pain catastrophizing and pain anxiety among individuals with chronic pain in the Emergency Department | 000 | 1 | NIH | 4/17/2026 | $170,640 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01HL179112 | Deciphering respiratory disease mechanisms through integration of genomic and functional data across massive global biobanks | 000 | 2 | NIH | 6/12/2026 | $773,633 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01DK146327 | BMP2/6 ligand formation and function in development and iron homeostasis | 000 | 1 | NIH | 1/26/2026 | $813,961 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R01NS149686 | Circadian regulation of reperfusion efficacy in acute ischemic stroke | 000 | 1 | NIH | 6/12/2026 | $648,672 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R00EB032749 | Wearable RF-EEG Cap for closed loop TMS/fMRI/EEG Applications | 000 | 4 | NIH | 6/3/2026 | $249,000 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R21NS145499 | Exercise Preconditioning and Compensatory Oligodendrogenesis in Subcortical Ischemic Vascular Dementia | 000 | 1 | NIH | 5/12/2026 | $439,150 |
| | 2026 | 2026 | THE GENERAL HOSPITAL CORPORATION | 55 FRUIT ST | BOSTON | MA | 02114-2621 | SUFFOLK | USA | R21EB037917 | Miniaturized No-Moving-Parts Scanning Light Endoscope | 000 | 1 | NIH | 6/9/2026 | $247,500 |
|
